HORIZON EUROPE
Europeo
Specific Challenge:People-centred care is one of the main goals of health systems[1]. It relates to a stronger orientation towards the needs of people and their involvement in the treatment process and decision-making. This is expected to result in a better care as experienced by people, in less inequality, better health promotion, better disease prevention, and treatments better targeted to people’s needs. Health system transition to people-centred care requires empowering citizens[2] and integration of services[3].
The growing digital transformation of health and care offers great opportunity to achieve this transition. Innovative solutions[4] involving digital tools have the potential to improve people-centred care through self-management, goal orientation and shared decision-making. However, technical innovation is unlikely to achieve the anticipated improvements/impact if not accompanied by supportive organisational and policy innovations. Given the complexity and differences between health systems, cross-national comparative health services and systems research as well as implementation research are needed to better understand the contextual factors that impact t...
ver más
Specific Challenge:People-centred care is one of the main goals of health systems[1]. It relates to a stronger orientation towards the needs of people and their involvement in the treatment process and decision-making. This is expected to result in a better care as experienced by people, in less inequality, better health promotion, better disease prevention, and treatments better targeted to people’s needs. Health system transition to people-centred care requires empowering citizens[2] and integration of services[3].
The growing digital transformation of health and care offers great opportunity to achieve this transition. Innovative solutions[4] involving digital tools have the potential to improve people-centred care through self-management, goal orientation and shared decision-making. However, technical innovation is unlikely to achieve the anticipated improvements/impact if not accompanied by supportive organisational and policy innovations. Given the complexity and differences between health systems, cross-national comparative health services and systems research as well as implementation research are needed to better understand the contextual factors that impact the successful introduction, use and sustainability of innovative solutions. This will in turn facilitate their scalability[5] and their transferability to other settings.
Scope:Proposals should study the scaling-up or transferability of an innovative solution involving digital tools, i.e. the conditions under which it can be implemented in other health systems and whether it can have the same intended effect.
To address this specific challenge, the proposals should:
Identify an innovative solution involving digital tools (or a set of comparable innovations developed in parallel in different settings) with the potential to enhance people-centred care. The selected innovative solution should be described and supported by sufficient documented evidence on its effectiveness in specific contexts and if possible cost-effectiveness.Design and conduct an implementation study to collect either prospectively or retrospectively (depending on the maturity of the innovative solution) the evidence needed to inform the successful scaling up or transfer to different health systems with particular focus on the contextual factors including legal, ethical, behavioural and social issues.Identify the key aspects for scaling up or transfer, identify potential barriers, necessary measures/changes as well as facilitators to adopt the solution.Develop a prediction model to help decision-makers decide on the implementation of the solution as well as guidance to assess the future impact of the transferred solution on health system performance. Proposals should be multidisciplinary, bringing together expertise in health services and systems research, human and social sciences and implementation research[6]. The main focus should be on improving people-centeredness in Europe but solutions can originate from non-European countries. Gender aspects should be taken into account. Careful consideration should be given to vulnerable groups. Relevant stakeholders including end-users of research and patients’ organisations should be identified and involved throughout the project lifetime. Innovative approaches in gathering patients input should be considered.
The proposals should complement or build on existing initiatives, including (but not limited to) results of EU-funded projects[7].
Selected proposals should provide evidence to support the third pillar of the Communication from the Commission on enabling the digital transformation of health and care in the Digital Single Market, ''Digital tools for citizens empowerment and person-centred care[8]".
The Commission considers that proposals requesting a contribution from the EU Horizon 2020 research programme of between EUR 3 and 4 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
Expected Impact:Availability of methods and strategies for the implementation of innovative, ethically and legally sustainable solutions aiming at improving people-centred careA better understanding of organisational and system changes, as well as social and behavioural changes required to successfully embed evidence-based innovative solutions involving digital tools into daily practice and ensure their sustainabilityIncreased scaling up and transfer of innovative solutions improving people-centred care in EuropeIn the medium and long-term, health services more responsive to the needs of people and their carers (formal and informal), more effective, efficient and equitable health systems.
Cross-cutting Priorities:GenderOpen Innovation
[1]World Health Organization 2016. What are integrated people-centred health services? https://www.who.int/servicedeliverysafety/areas/people-centred-care/ipchs-what/en/
[2]Empowering citizens refers among others to enhancing their self management, raising health literacy, involving people through co-production of care and supporting informal carers.
[3]The concepts of integrated services and people-centred care are complementary to each other. Person-centredness not only requires involving people to explore their needs and come to shared decisions about treatment, but also a system-wide policy and organisation of services. Integrated care principles allow care for patients to be better coordinated, and jointly planned by the health and social care professionals across relevant preventive and curative services.
[4]The term “innovative solutions” refers to any service or policy innovations. It encompasses technological innovations, organisational innovations and public health policies. Organisational innovation should be understand in a broad sense including governance, payment, information systems, roles and skills in attaining efficient health care organisations when introducing new technologies.
[5]Scalability is used in the sense of the uptake in larger numbers of the same innovation in comparable organisations and/or in the same sector.
[6]Implementation research refers to the scientific study of methods to promote the uptake of research findings into routine healthcare in clinical, organizational or policy contexts
[7]e.g. TO-REACH, ImpleMentAll, TICD, PROJECT INTEGRATE, SELFIE, SMART2D
[8]https://ec.europa.eu/digital-single-market/en/news/communication-enabling-digital-transformation-health-and-care-digital-single-market-empowering
ver menos
Características del consorcio
:
La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Características del Proyecto
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Características de la financiación
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects. See the information in the Online Manual.
Also, in recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding to support its participation in projects supported under this topic.
2. Eligibility and admissibility conditions: described in Annex B and Annex C of the Work Programme.
Proposal page limits and layout: please refer to Part B of the proposal template in the submission system below.
3. Evaluation:
Evaluation criteria, scoring and thresholds are described in Annex H of the Work Programme.
Submission and evaluation processes are described in the Online Manual.
The thresholds for each criterion for the second stage of the two-stage calls for these topics will be 4 (Excellence), 4 (Impact) and 3 (Implementation). The cumulative threshold will be 12.
4. Indicative time for evaluation and grant agreements:
Information on the outcome of evaluation (two-stage call):
For stage 1: maximum 3 months from the deadline for submission.
For stage 2: maximum 5 months... 1. Eligible countries: described in Annex A of the Work Programme.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects. See the information in the Online Manual.
Also, in recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding to support its participation in projects supported under this topic.
2. Eligibility and admissibility conditions: described in Annex B and Annex C of the Work Programme.
Proposal page limits and layout: please refer to Part B of the proposal template in the submission system below.
3. Evaluation:
Evaluation criteria, scoring and thresholds are described in Annex H of the Work Programme.
Submission and evaluation processes are described in the Online Manual.
The thresholds for each criterion for the second stage of the two-stage calls for these topics will be 4 (Excellence), 4 (Impact) and 3 (Implementation). The cumulative threshold will be 12.
4. Indicative time for evaluation and grant agreements:
Information on the outcome of evaluation (two-stage call):
For stage 1: maximum 3 months from the deadline for submission.
For stage 2: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
5. Proposal templates, evaluation forms and model grant agreements (MGA):
Research and Innovation Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
General MGA - Multi-Beneficiary
Annotated Grant Agreement
Essential information for clinical trials
6. Additional provisions:
Horizon 2020 budget flexibility
Classified information
Technology readiness levels (TRL) – where a topic description refers to TRL, these definitions apply.
Members of consortium are required to conclude a consortium agreement, in principle prior to the signature of the grant agreement.
8. Additional documents:
Introduction WP 2018-20
Health, demographic change and well-being WP 2018-20
General annexes to the Work Programme 2018-2020
Legal basis: Horizon 2020 Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
7. Open access must be granted to all scientific publications resulting from Horizon 2020 actions.
Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
Open access to research data
The Open Research Data Pilot has been extended to cover all Horizon 2020 topics for which the submission is opened on 26 July 2016 or later. Projects funded under this topic will therefore by default provide open access to the research data they generate, except if they decide to opt-out under the conditions described in Annex L of the Work Programme. Projects can opt-out at any stage, that is both before and after the grant signature.
Note that the evaluation phase proposals will not be evaluated more favourably because they plan to open or share their data, and will not be penalised for opting out.
Open research data sharing applies to the data needed to validate the results presented in scientific publications. Additionally, projects can choose to make other data available open access and need to describe their approach in a Data Management Plan.
Projects need to create a Data Management Plan (DMP), except if they opt-out of making their research data open access. A first version of the DMP must be provided as an early deliverable within six months of the project and should be updated during the project as appropriate. The Commission already provides guidance documents, including a template for DMPs. See the Online Manual.
Eligibility of costs: costs related to data management and data sharing are eligible for reimbursement during the project duration.
The legal requirements for projects participating in this pilot are in the article 29.3 of the Model Grant Agreement.
Información adicional de la convocatoria
Otras ventajas
Ayudas Similares
| Abierta
| Próximamente
| Abierta